Cargando…
Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation
BACKGROUND: Brown adipose tissue [BAT] metabolism in vivo is vital for the development of novel strategies in combating obesity and diabetes. Currently, BAT is activated at low temperatures and measured using 2-deoxy-2-(18)F-fluoro-D-glucose [(18)F-FDG] positron-emission tomography [PET]. We report...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250993/ https://www.ncbi.nlm.nih.gov/pubmed/22214183 http://dx.doi.org/10.1186/2191-219X-1-30 |
_version_ | 1782220512920862720 |
---|---|
author | Mirbolooki, M Reza Constantinescu, Cristian C Pan, Min-Liang Mukherjee, Jogeshwar |
author_facet | Mirbolooki, M Reza Constantinescu, Cristian C Pan, Min-Liang Mukherjee, Jogeshwar |
author_sort | Mirbolooki, M Reza |
collection | PubMed |
description | BACKGROUND: Brown adipose tissue [BAT] metabolism in vivo is vital for the development of novel strategies in combating obesity and diabetes. Currently, BAT is activated at low temperatures and measured using 2-deoxy-2-(18)F-fluoro-D-glucose [(18)F-FDG] positron-emission tomography [PET]. We report the use of β3-adrenergic receptor-mediated activation of BAT at ambient temperatures using (R, R)-5-[2-[2,3-(3-chlorphenyl)-2-hydroxyethyl-amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate, disodium salt [CL316,243] (a selective β3-adrenoceptor agonist) and measured by (18)F-FDG PET/computed tomography [CT]. METHODS: Control and CL316,243-treated (2 mg/kg) male Sprague-Dawley rats were administered with (18)F-FDG for PET/CT studies and were compared to animals at cold temperatures. Receptor-blocking experiments were carried out using propranolol (5 mg/kg). Dose effects of CL316,243 were studied by injecting 0.1 to 1 mg/kg 30 min prior to (18)F-FDG administration. Imaging results were confirmed by autoradiography, and histology was done to confirm BAT activation. RESULTS: CL316,243-activated interscapular BAT [IBAT], cervical, periaortic, and intercostal BATs were clearly visualized by PET. (18)F-FDG uptake of IBAT was increased 12-fold by CL316,243 vs. 1.1-fold by cold exposure when compared to controls. (18)F-FDG uptake of the CL-activated IBAT was reduced by 96.0% using intraperitoneal administration of propranolol. Average (18)F-FDG uptake of IBAT increased 3.6-, 3.5-, and 7.6-fold by doses of 0.1, 0.5, and 1 mg/kg CL, respectively. Ex vivo (18)F-FDG autoradiography and histology of transverse sections of IBAT confirmed intense uptake in the CL-activated group and activated IBAT visualized by PET. CONCLUSION: Our study indicated that BAT metabolic activity could be evaluated by (18)F-FDG PET using CL316,243 at ambient temperature in the rodent model. This provides a feasible and reliable method to study BAT metabolism. |
format | Online Article Text |
id | pubmed-3250993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Springer |
record_format | MEDLINE/PubMed |
spelling | pubmed-32509932012-02-03 Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation Mirbolooki, M Reza Constantinescu, Cristian C Pan, Min-Liang Mukherjee, Jogeshwar EJNMMI Res Original Research BACKGROUND: Brown adipose tissue [BAT] metabolism in vivo is vital for the development of novel strategies in combating obesity and diabetes. Currently, BAT is activated at low temperatures and measured using 2-deoxy-2-(18)F-fluoro-D-glucose [(18)F-FDG] positron-emission tomography [PET]. We report the use of β3-adrenergic receptor-mediated activation of BAT at ambient temperatures using (R, R)-5-[2-[2,3-(3-chlorphenyl)-2-hydroxyethyl-amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate, disodium salt [CL316,243] (a selective β3-adrenoceptor agonist) and measured by (18)F-FDG PET/computed tomography [CT]. METHODS: Control and CL316,243-treated (2 mg/kg) male Sprague-Dawley rats were administered with (18)F-FDG for PET/CT studies and were compared to animals at cold temperatures. Receptor-blocking experiments were carried out using propranolol (5 mg/kg). Dose effects of CL316,243 were studied by injecting 0.1 to 1 mg/kg 30 min prior to (18)F-FDG administration. Imaging results were confirmed by autoradiography, and histology was done to confirm BAT activation. RESULTS: CL316,243-activated interscapular BAT [IBAT], cervical, periaortic, and intercostal BATs were clearly visualized by PET. (18)F-FDG uptake of IBAT was increased 12-fold by CL316,243 vs. 1.1-fold by cold exposure when compared to controls. (18)F-FDG uptake of the CL-activated IBAT was reduced by 96.0% using intraperitoneal administration of propranolol. Average (18)F-FDG uptake of IBAT increased 3.6-, 3.5-, and 7.6-fold by doses of 0.1, 0.5, and 1 mg/kg CL, respectively. Ex vivo (18)F-FDG autoradiography and histology of transverse sections of IBAT confirmed intense uptake in the CL-activated group and activated IBAT visualized by PET. CONCLUSION: Our study indicated that BAT metabolic activity could be evaluated by (18)F-FDG PET using CL316,243 at ambient temperature in the rodent model. This provides a feasible and reliable method to study BAT metabolism. Springer 2011-12-01 /pmc/articles/PMC3250993/ /pubmed/22214183 http://dx.doi.org/10.1186/2191-219X-1-30 Text en Copyright © 2011 Mirbolooki et al; licensee Springer. https://creativecommons.org/licenses/by/2.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0 (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Mirbolooki, M Reza Constantinescu, Cristian C Pan, Min-Liang Mukherjee, Jogeshwar Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation |
title | Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation |
title_full | Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation |
title_fullStr | Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation |
title_full_unstemmed | Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation |
title_short | Quantitative assessment of brown adipose tissue metabolic activity and volume using (18)F-FDG PET/CT and β3-adrenergic receptor activation |
title_sort | quantitative assessment of brown adipose tissue metabolic activity and volume using (18)f-fdg pet/ct and β3-adrenergic receptor activation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250993/ https://www.ncbi.nlm.nih.gov/pubmed/22214183 http://dx.doi.org/10.1186/2191-219X-1-30 |
work_keys_str_mv | AT mirbolookimreza quantitativeassessmentofbrownadiposetissuemetabolicactivityandvolumeusing18ffdgpetctandb3adrenergicreceptoractivation AT constantinescucristianc quantitativeassessmentofbrownadiposetissuemetabolicactivityandvolumeusing18ffdgpetctandb3adrenergicreceptoractivation AT panminliang quantitativeassessmentofbrownadiposetissuemetabolicactivityandvolumeusing18ffdgpetctandb3adrenergicreceptoractivation AT mukherjeejogeshwar quantitativeassessmentofbrownadiposetissuemetabolicactivityandvolumeusing18ffdgpetctandb3adrenergicreceptoractivation |